Tag: IPO
-
Venture Rounds, IPOs, Mergers Vanish in Election Week
Nationwide jitters in the U.S. appear to be affecting venture capital activities in the week of the presidential and congressional elections.
-
Covid-19 Drug Biotech Raises $300M in IPO
A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial public offering, or IPO, for common stock.
-
Mental Health Drug Company Raises $127.5M in IPO
A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $127.5 million in its initial public stock offer.
-
Cancer Protein Therapy Biotech Raises $400M in IPO
A three year-old company developing protein-targeted cancer therapies with computational techniques is raising $400 million in its initial public offering of common stock.
-
Migraine Drug Developer Raises $82.5M in IPO
A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock.
-
Two Biotechs Each Issue $300M+ IPOs
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions.
-
Genome Editing Biotech Raises $126M in IPO
A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock.
-
Infographic – Tech IPOs Flat in 2018
CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017.
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.
-
Synthetic DNA Company Raising $70 Million in IPO
A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering.